Village Farms International (VFF) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Achieved record consolidated sales of $92.1 million in Q2 2024, up 19% year-over-year, driven by Canadian cannabis and strong fresh produce performance.
Canadian cannabis sales grew 45% year-over-year to $40.7 million (CAD 55.8 million), with branded retail sales up 38% and international sales up 11%.
Canadian cannabis delivered positive adjusted EBITDA and operating cash flow, expanding its number two national market share.
Fresh produce segment tied its second-highest quarterly sales in five years, up 7% year-over-year, despite pricing pressures.
U.S. cannabis segment faced challenges, with net sales declining and a significant goodwill impairment.
Financial highlights
Consolidated net loss was $23.5 million, or $0.21 per share, compared to a $1.4 million loss last year, impacted by a $11.9 million U.S. cannabis impairment.
Adjusted EBITDA was -$3.6 million, compared to -$1.1 million last year, excluding a prior period legal settlement.
Cash flow from operations improved to $5.7 million (CAD 5.7 million), a significant improvement from a $5.2 million outflow last year.
Canadian cannabis gross margin was 26% in Q2, impacted by non-branded inventory sales.
Ended Q2 with $29.7 million in cash and working capital of CAD 6.1 million.
Outlook and guidance
Expect significantly improved performance for fresh produce in the second half of 2024 due to better pricing and supply dynamics.
Canadian cannabis gross margin guidance remains at 30%-40%, with ongoing SKU and profitability optimization.
Netherlands facility on track for first sales in Q1 2025, with strong anticipated demand and no excise tax.
Canadian cannabis expected to sustain growth with gains across brands, form factors, and geographies, and benefit from near-term international opportunities.
Latest events from Village Farms International
- Record 2025 profit, strong cannabis sales, and expansions support future growth.VFF
Q4 202512 Mar 2026 - All director nominees and motions were approved, with final results to be published.VFF
AGM 20243 Feb 2026 - Q3 sales up 20%, driven by Canadian cannabis, fresh produce, and international growth.VFF
Q3 202416 Jan 2026 - All director nominees and motions were approved, with final results to be published.VFF
AGM 20256 Jan 2026 - Full-year sales up 18% to CAD 336M; international medicinal sales to triple in 2025.VFF
Q4 202425 Dec 2025 - Plans to raise up to $200 million for growth via a multi-security shelf registration.VFF
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor, with focus on governance and diversity.VFF
Proxy Filing2 Dec 2025 - Canadian Cannabis EBITDA up 64%, international exports up 285%, $40M produce asset sale.VFF
Q1 202526 Nov 2025 - Record Q2 profit, surging cannabis margins, and global expansion drive strong outlook.VFF
Q2 202523 Nov 2025